Efficacy of montelukast in attenuating the September epidemic of asthma exacerbations

M. Guerra, M. Canciani

Source: Breathe 2007; 4: 164

Journal Issue: December

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Guerra, M. Canciani. Efficacy of montelukast in attenuating the September epidemic of asthma exacerbations. Breathe 2007; 4: 164

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Could montelukast reduce asthma exacerbations? Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
Clinical efficacy of nebulised budesonide in acute exacerbation of COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Comparison of formoterol and terbutaline for treatment of asthma exacerbations in children and adolescents Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004
Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma Source: Eur Respir J, 57 (2) 2002436; 10.1183/13993003.02436-2020 Year: 2021
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004
Montelukast and frequency of exacerbations of asthma Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011
Perceived bronchodilator efficacy during severe asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Efficacy of montelukast in Indian patients having chronic persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 372s Year: 2003
Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006
Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
Asthma exacerbations in children receiving montelukast vs. other controllers in Italy Source: Eur Respir J 2005; 26: Suppl. 49, 618s Year: 2005
Association of β₂-adrenoreceptor genotypes with prevention of COPD exacerbations by tiotropium or salmeterol in the POET-COPD® trial Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
The role of nebulised budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2007; 30: 399-400 Year: 2007
Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose Year: 2018
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
ERJ August Podcast: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids Source: Eur Respir J, 50 (2) 17E5002; 10.1183/13993003.E5002-2017 Year: 2017